EP2377869
Nýsmíði á bortezómíbi
Status:
EP Einkaleyfi útrunniðEP appl. date:
24.3.2005EP published:
29.1.2014EP application number:
11167264.8
EP translation filed:
28.4.2014Grant published:
15.5.2014EPO information:
European Patent Register
Max expiry date:
23.3.2025Expiry date:
23.3.2025
Title:
Synthesis of Bortezomib
Timeline
Owner
Name:
MILLENNIUM PHARMACEUTICALS, INC.Address:
40 Landsdowne Street, 02139, Cambridge, MA, US
Inventor
Name:
Pickersgill, I. FraserAddress:
Newton, MA, US
Name:
Bishop, JohnAddress:
Groton, MA, US
Name:
Ammoscato, VinceAddress:
Riverview, MI, US
Name:
Munk, StephenAddress:
Riverview, MI, US
Name:
Lo, YoungAddress:
Petersburg, VA, US
Name:
Chiu, Fang-TingAddress:
Petersburg, VA, US
Name:
Kulkarni, Vithalanand R.Address:
Petersburg, VA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
557535 PDate:
30.3.2004Country:
US
Classification
Categories:
C07F 5/02, C07F 5/04
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 23.4.2014
Expires: 23.3.2015
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 3.3.2015
Expires: 23.3.2016
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 1.3.2016
Expires: 23.3.2017
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 2.3.2017
Expires: 23.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 2.3.2018
Expires: 23.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 4.3.2019
Expires: 23.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 3.3.2020
Expires: 23.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 2.3.2021
Expires: 23.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 18
Paid: 17.2.2022
Expires: 23.3.2023
Payer: Patice ehf.
Number: 19
Paid: 22.2.2023
Expires: 23.3.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 6.3.2024
Expires: 23.3.2025
Payer: Árnason Faktor ehf.